SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-4,215 Cr | ₹-3,932 Cr | ₹-3,487 Cr | ₹-2,818 Cr | ₹-3,512 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-4,215 Cr |
Mar2024 | ₹-3,932 Cr |
Mar2023 | ₹-3,487 Cr |
Mar2022 | ₹-2,818 Cr |
Mar2021 | ₹-3,512 Cr |
How is Deferred Tax Assets / Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-4,215 Cr | Negative | |
Mar2024 | ₹-3,932 Cr | Negative | |
Mar2023 | ₹-3,487 Cr | Negative | |
Mar2022 | ₹-2,818 Cr | Negative | |
Mar2021 | ₹-3,512 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹382,472.4 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
MANKIND PHARMA | ₹105,380.0 Cr | -0.6% | 5.1% | 31.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -6.5% |
-4.7% |
-5.1% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses